415 related articles for article (PubMed ID: 15338271)
21. Differential neutrophil infiltration contributes to regional differences in brain inflammation in the substantia nigra pars compacta and cortex.
Ji KA; Eu MY; Kang SH; Gwag BJ; Jou I; Joe EH
Glia; 2008 Aug; 56(10):1039-47. PubMed ID: 18381656
[TBL] [Abstract][Full Text] [Related]
22. Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia.
Peng GS; Li G; Tzeng NS; Chen PS; Chuang DM; Hsu YD; Yang S; Hong JS
Brain Res Mol Brain Res; 2005 Mar; 134(1):162-9. PubMed ID: 15790540
[TBL] [Abstract][Full Text] [Related]
23. The brain as a target for inflammatory processes and neuroprotective strategies.
Skaper SD
Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
[TBL] [Abstract][Full Text] [Related]
24. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.
Tripanichkul W; Sripanichkulchai K; Finkelstein DI
Brain Res; 2006 Apr; 1084(1):28-37. PubMed ID: 16564034
[TBL] [Abstract][Full Text] [Related]
25. Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson's disease.
Kostuk EW; Cai J; Iacovitti L
J Neuroinflammation; 2018 May; 15(1):139. PubMed ID: 29751760
[TBL] [Abstract][Full Text] [Related]
26. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
Morale MC; Serra PA; L'episcopo F; Tirolo C; Caniglia S; Testa N; Gennuso F; Giaquinta G; Rocchitta G; Desole MS; Miele E; Marchetti B
Neuroscience; 2006; 138(3):869-78. PubMed ID: 16337092
[TBL] [Abstract][Full Text] [Related]
27. Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway.
Marchetti B; Serra PA; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Cioni S; Gennuso F; Rocchitta G; Desole MS; Mazzarino MC; Miele E; Morale MC
Ann N Y Acad Sci; 2005 Dec; 1057():296-318. PubMed ID: 16399902
[TBL] [Abstract][Full Text] [Related]
28. Microglial activation is not prevented by tacrolimus but dopamine neuron damage is reduced in a rat model of Parkinson's disease progression.
Wright AK; Miller C; Williams M; Arbuthnott G
Brain Res; 2008 Jun; 1216():78-86. PubMed ID: 18495090
[TBL] [Abstract][Full Text] [Related]
29. [Parkinson disease: mechanisms of cell death].
Michel PP; Hirsch EC; Agid Y
Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S24-32. PubMed ID: 12690661
[TBL] [Abstract][Full Text] [Related]
30. Is Parkinson's disease an autoimmune disorder of endogenous vasoactive neuropeptides?
Staines DR
Med Hypotheses; 2007; 69(6):1208-11. PubMed ID: 17562359
[TBL] [Abstract][Full Text] [Related]
31. Persistent phagocytic characteristics of microglia in the substantia nigra of long-term Parkinsonian macaques.
Barcia C; Ros CM; Ros-Bernal F; Gómez A; Annese V; Carrillo-de Sauvage MA; Yuste JE; Campuzano CM; de Pablos V; Fernández-Villalba E; Herrero MT
J Neuroimmunol; 2013 Aug; 261(1-2):60-6. PubMed ID: 23759319
[TBL] [Abstract][Full Text] [Related]
32. The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease.
Mirza B; Hadberg H; Thomsen P; Moos T
Neuroscience; 2000; 95(2):425-32. PubMed ID: 10658622
[TBL] [Abstract][Full Text] [Related]
33. Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra.
Ferrari CC; Pott Godoy MC; Tarelli R; Chertoff M; Depino AM; Pitossi FJ
Neurobiol Dis; 2006 Oct; 24(1):183-93. PubMed ID: 16901708
[TBL] [Abstract][Full Text] [Related]
34. [Parkinson's disease: cell death mechanisms].
Michel PP; Hirsch EC; Agid Y
Rev Neurol (Paris); 2002; 158(122):24-32. PubMed ID: 12690312
[TBL] [Abstract][Full Text] [Related]
35. Inflammation in Parkinson's disease.
Tufekci KU; Meuwissen R; Genc S; Genc K
Adv Protein Chem Struct Biol; 2012; 88():69-132. PubMed ID: 22814707
[TBL] [Abstract][Full Text] [Related]
36. Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys.
Miklossy J; Doudet DD; Schwab C; Yu S; McGeer EG; McGeer PL
Exp Neurol; 2006 Feb; 197(2):275-83. PubMed ID: 16336966
[TBL] [Abstract][Full Text] [Related]
37. Effects of aging on neuroprotective and neurotoxic properties of microglia in neurodegenerative diseases.
Sawada M; Sawada H; Nagatsu T
Neurodegener Dis; 2008; 5(3-4):254-6. PubMed ID: 18322405
[TBL] [Abstract][Full Text] [Related]
38. Astrocytes and microglia: responses to neuropathological conditions.
Singh S; Swarnkar S; Goswami P; Nath C
Int J Neurosci; 2011 Nov; 121(11):589-97. PubMed ID: 21827229
[TBL] [Abstract][Full Text] [Related]
39. Neuroinflammatory processes in Parkinson's disease.
Hunot S; Hirsch EC
Ann Neurol; 2003; 53 Suppl 3():S49-58; discussion S58-60. PubMed ID: 12666098
[TBL] [Abstract][Full Text] [Related]
40. Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP.
Kim S; Cho SH; Kim KY; Shin KY; Kim HS; Park CH; Chang KA; Lee SH; Cho D; Suh YH
J Neurochem; 2009 Jun; 109(5):1483-96. PubMed ID: 19457162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
